Original language | English |
---|---|
Journal | Blood Neoplasia |
Publication status | Accepted/In press - 21 Apr 2024 |
Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS
Research output: Contribution to journal › Article › peer-review